CME Group USD Malaysian Crude Palm Oil futures volume and open interest

In September 2023, CME Group Crude Palm Oil volume totaled 25,720 lots (643,000 metric tons) and the end-of-month open interest was 48,509 lots (1,212,725 metric tons).

Volume in the first three contract months was 6,850, which was about 27% of the total monthly volume.

End-of-month open interest in the first three contract months was 16,339, which was about 34% of the total open interest.

USD Malaysian Crude Palm Oil price and volatility

USD Malaysian Crude Palm Oil futures* settles at $808.25 per metric ton at the end of September 2023, creating a -$60.75 price movement from a month ago.

During the month, 20-day rolling volatility ranged from 21.5% to 29.0%, with an average of 25.2%.

Bean Oil – Palm Oil Spread, Palm Oil – Gasoil spread price and Palm Oil FOB Indonesia basis price

Bean Oil – Palm Oil (BOPO)** price decreased from $575.91 per ton at the end of the previous month to $458.08 per ton at the end of Sep-2023. The monthly movement was -$117.82.

Palm Oil – Gasoil (POGO)*** decreased from -$17.00 per ton at the end of the previous month to -$170.82 per ton at the end of the month. The monthly movement was -$153.82.

The FOB Indonesia Basis****, the price spread between Indonesian and Malaysian Crude Palm Oil, increased from $11.00 per ton at the end of the previous month to $34.25 per ton at the end of the month. The monthly movement was $23.25.

Indonesian crude palm oil prices were not assessed during May 2022. In addition, the FOB Indonesia basis prices starting June 2022 were calculated using Refinitiv crude palm oil FOB Indonesia second forward month prices, instead of the third forward month.


* Based on USD Malaysian Crude Palm Oil futures first nearby contract month that is not in the monthly averaging period. Contract month rolls at the beginning of each month.

** Defined as the differential of settlement price between front month CBOT Soybean Oil futures converted into USD/MT and USD Malaysian Crude Palm Oil futures first nearby contract month that is not in the monthly averaging period.

*** Defined as the differential of settlement price between USD Malaysian Crude Palm Oil futures and European Low Sulphur Gasoil futures first nearby contract months that are not in the monthly averaging period.

**** Calculated as the differential between the Refinitiv crude palm oil FOB Indonesia third forward month price and the settlement price of USD Malaysian Crude Palm Oil futures first nearby contract month that is not in the monthly averaging period.

Explore our Palm Oil products

Explore the efficiency and transparency of listed futures and options on futures.


Disclaimer

Exchange traded derivatives and cleared over-the-counter (“OTC”) derivatives are not suitable for all investors and involve the risk of loss. Exchange traded and OTC derivatives are leveraged instruments and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money initially deposited. This communication does not (within the meaning of any applicable legislation) constitute a Prospectus or a public offering of securities; nor is it a recommendation, offer, invitation or solicitation to buy, sell or retain any specific investment or service.

The content in this communication has been compiled by CME Group for general purposes only and is not intended to provide, and should not be construed as advice. It does not take into account your objectives, financial situation or needs, and you should obtain appropriate professional advice before acting on or relying on the information set out in this communication. Although every attempt has been made to ensure the accuracy of the information within this communication as of the date of publication, CME Group assumes no responsibility for any errors or omissions and will not update it. Additionally, all examples and information in this communication are used for explanation purposes only and should not be considered, investment advice, the results of actual market experience, or the promotion of any particular products or services.  All matters pertaining to rules and specifications herein are made subject to and superseded by official Chicago Mercantile Exchange Inc. (“CME”), the Chicago Board of Trade, Inc. (“CBOT”), the New York Mercantile Exchange, Inc. (“NYMEX”), and the Commodity Exchange, Inc. (“COMEX”) rulebooks or, as applicable, the respective Rulebooks of CME Group’s certain other subsidiary trading facilities. Current rules should be consulted in all cases including matters relevant to contract specifications.

 CME Group does not represent that any material or information contained in this communication is appropriate for use or permitted in any jurisdiction or country where such use or distribution would be contrary to any applicable law or regulation. This communication has not been reviewed or approved by any regulatory authority and access shall be at the liability of the user.

In Australia, each of Chicago Mercantile Exchange Inc. (ARBN 103 432 391), Board of Trade of the City of Chicago Inc. (ARBN 110 594 459), New York Mercantile Exchange, Inc. (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence.

In Hong Kong, CME, CBOT, NYMEX and COMEX are authorized by the Hong Kong Securities and Futures Commission (the "SFC") to provide Automated Trading Services ("ATS") via the CME GLOBEX system, and CME is authorized by the SFC to provide ATS via the CME Clearing System, under Part III of the Securities and Futures Ordinance (the "SFO"). 

In Japan, CME has a Foreign Clearing Organisation (FCO) license under the Financial Instruments and Exchange Act of Japan.

In Singapore, CME, CBOT, NYMEX and COMEX are regulated as a recognized market operator and CME is regulated as a recognized clearing house under the Securities and Futures Act (Chapter 289) ("SFA"). Save as aforesaid, none of the CME Group entities are licensed to carry on regulated activities under the SFA or to provide financial advisory services under the Financial Advisers Act (Chapter 110) in Singapore.

None of CME Group entities are registered or licensed to provide, nor does it purport to provide, financial services of any kind in some jurisdictions, including, but not limited to, India, Korea, Malaysia, New Zealand, People’s Republic of China, Philippines, Thailand, and Vietnam and in any jurisdiction where CME Group is not authorized to do business or where such distribution would be contrary to the local laws and regulations. 

You are advised to exercise caution in relation to the information contained herein. If you are in any doubt about any of the contents of this communication, you should obtain independent professional advice. 

In Hong Kong, CME Group is not licensed to carry on business in dealing or advising on futures contracts under the SFO. This communication is for distribution in Hong Kong solely to corporations licensed by the SFC under Part V or authorized under Part III of the SFO.

In Japan, this communication is for distribution solely to certain qualified sophisticated investors as set forth in the Commodities Futures Act of Japan (Law No. 239 of 1950, as amended) and the related rules, as appropriate. Other than that, the information contained in this communication is not directed at any person in Japan and is not intended for marketing or soliciting Japanese customers to trade or use any specific CME products or services.

In the Republic of Korea, this communication is for distribution solely to “professional investors” (as defined in Article 9(5) of the Financial Investment Services and Capital Markets Act and related rules) in response to a request from such professional investors or through a licensed investment broker.

In the People’s Republic of China, this communication is provided to the reader only and shall not be copied or redistributed within the People’s Republic of China for any other purpose. No information contained in this communication constitutes or leads to an offer to provide or sell any financial service or product, a recommendation (express or implied) to take any action in respect of any financial product, or any investment advice or market forecast.

This communication is for distribution in Singapore solely to certain institutional investors (such as persons holding a capital markets services licence for trading in futures contracts or exempt from such requirements under the SFA), to accredited investors and to expert investors (each as defined in the SFA).

CME Group, the Globe Logo, CME, Globex, E-Mini, CME Direct, CME DataMine and Chicago Mercantile Exchange are trademarks of Chicago Mercantile Exchange Inc.  CBOT and the Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago, Inc.  NYMEX and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.

BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.

Certain CME Group subsidiaries are authorised and regulated by regulatory authorities. Certain of those subsidiaries are required to retain records of telephone conversations and other electronic communications for a period of 5 to 7 years where required by certain regulation, copies of which are available on request (which may be subject to a fee). For further regulatory information please see www.cmegroup.com. 

Copyright © 2023 CME Group Inc. All rights reserved.
Mailing Address: 20 South Wacker Drive, Chicago, Illinois 60606

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2023 CME Group Inc. All rights reserved.